Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Avalon Globocare (AVCO)

Avalon Globocare (AVCO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 100,085
  • Shares Outstanding, K 80,068
  • Annual Sales, $ 1,550 K
  • Annual Income, $ -18,070 K
  • 60-Month Beta 0.48
  • Price/Sales 65.26
  • Price/Cash Flow N/A
  • Price/Book 21.09

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1300 +0.16%
on 09/04/20
1.5900 -28.82%
on 08/24/20
-0.4082 (-26.51%)
since 08/21/20
3-Month
1.1300 +0.16%
on 09/04/20
2.1600 -47.60%
on 08/19/20
-0.4982 (-30.56%)
since 06/23/20
52-Week
0.5000 +126.36%
on 03/12/20
2.5200 -55.09%
on 09/24/19
-1.2382 (-52.24%)
since 09/23/19

Most Recent Stories

More News
IPA CEO to Participate in Virtual Panel: "New Approaches to COVID-19: Hidden Breakthroughs," on Thursday, September 10th

IPA CEO to Participate in Virtual Panel: "New Approaches to COVID-19: Hidden Breakthroughs," on Thursday, September 10th

IPA.VN : 2.370 (-6.32%)
IPATF : 1.7756 (-5.55%)
AVCO : 1.1500 (-8.00%)
HTBX : 1.2600 (-10.64%)
ORGS : 4.77 (-4.98%)
AIM ImmunoTech CEO to Participate in Virtual Panel: 'New Approaches to COVID-19: Hidden Breakthroughs,' on Thursday, September 10th

OCALA, FL / ACCESSWIRE / September 8, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM), today announced that Thomas K. Equels, CEO of AIM ImmunoTech, will participate in a virtual panel titled, "New Approaches...

AIM : 2.27 (-10.63%)
AVCO : 1.1500 (-8.00%)
HTBX : 1.2600 (-10.64%)
IPA.VN : 2.370 (-6.32%)
IPATF : 1.7756 (-5.55%)
ORGS : 4.77 (-4.98%)
Avalon GloboCare CEO to Participate in Virtual Panel: "New Approaches to COVID-19: Hidden Breakthroughs," on Thursday, September 10th

Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announced that Dr. David Jin, M.D., Ph.D., President...

HTBX : 1.2600 (-10.64%)
IPATF : 1.7756 (-5.55%)
ORGS : 4.77 (-4.98%)
AVCO : 1.1500 (-8.00%)
Avalon GloboCare Announces Mesenchymal Stromal Cell Therapeutic Platform for COVID-19 and Acute Graft Versus Host Disease (aGVHD)

Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announced the launch of its new allogeneic mesenchymal...

AVCO : 1.1500 (-8.00%)
Global HDPE Pipes Market (Value, Volume): Analysis By Grade Type (PE63, PE80, PE100, Others), Application, Diameter, By Region, By Country (2020 Edition): Market Insights and Outlook Post Covid-19 Pandemic (2020-2025)

, /PRNewswire/ -- The Global HDPE Pipes Market was valued at in the year 2019. Growing demand for HDPE pipes for water irrigation systems in agriculture industry coupled with rising sewage disposal infrastructure...

AVCO : 1.1500 (-8.00%)
Restrictions to Control the Spread of the Virus are also Disrupting the Global Supply Chain for Inhalers

VANCOUVER, British Columbia, /PRNewswire/ --   – While it may be hard to conceive that a single mineral could be responsible for over 80% of the inhalers in current use, it's even harder to swallow...

AVCO : 1.1500 (-8.00%)
MOS : 18.26 (+1.16%)
MXCHF : 1.6201 (-4.14%)
BHP : 51.83 (-2.00%)
ARS.VN : 0.160 (+6.67%)
ARSMF : 0.1222 (+6.72%)
Avalon GloboCare Announces Commercialization and Distribution Agreement with Cellex for COVID-19 Antibody Rapid Test Kit

Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announced that the Company has entered into a commercialization...

AVCO : 1.1500 (-8.00%)
Avalon GloboCare Expands AVA-Trap(TM) Program to Treat COVID-19 and CAR-T Related Cytokine Storms

-- Expands and files two USPTO provisional patent applications jointly with the Massachusetts Institute of Technology (MIT) Media Lab to develop a cytokine-specific blood purification system based on Avalon's...

AVCO : 1.1500 (-8.00%)
Avalon GloboCare Achieves Milestones in Advancing Novel Intranasal and Oral COVID-19 Vaccine Candidate

- Avalon forms strategic partnership with the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria and the nanotechnology laboratory of Professor Uwe B. Sleytr on a novel S-layer...

AVCO : 1.1500 (-8.00%)
Eminent Member of the Austrian Academy of Sciences, Professor Uwe B. Sleytr, Joins Avalon GloboCare's Scientific and Clinical Advisory Board

Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, announced today that the Company has appointed Professor Uwe B. Sleytr to its Scientific...

AVCO : 1.1500 (-8.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Trade AVCO with:

Business Summary

Avalon GloboCare Corp. outsourced healthcare services. It serves healthcare institutions, individual patients, academia and corporations sector. The company provides healthcare management which comprises cell-based technologies and therapeutics, genomic diagnostics and precision medicine, international...

See More

Key Turning Points

2nd Resistance Point 1.2967
1st Resistance Point 1.2733
Last Price 1.1500
1st Support Level 1.2233
2nd Support Level 1.1967

See More

52-Week High 2.5200
Fibonacci 61.8% 1.7484
Fibonacci 50% 1.5100
Fibonacci 38.2% 1.2716
Last Price 1.1500
52-Week Low 0.5000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar